Literature DB >> 3802437

The association of postural changes in systolic blood pressure and mortality in persons with hypertension: the Hypertension Detection and Follow-up Program experience.

B R Davis, H G Langford, M D Blaufox, J D Curb, B F Polk, N B Shulman.   

Abstract

Participants in the Hypertension Detection and Follow-up Program (HDFP) were classified on the basis of baseline standing minus sitting systolic blood pressure into four groups (less than or equal to -20 [group 1], -19 to 0 [group 2], 1 to 20 [group 3], and greater than 20 mm Hg [group 4]) to study 5 year mortality. Group 1, 3.3% of the total, contained those participants who had postural hypotension. The 5 year total and age-adjusted mortality rates for these groups were significantly different (p less than .04), with group 1 having the highest rates. To account for the possible confounding effects of certain baseline risk factors--age, sex, race, prior antihypertensive treatment, randomization group, diabetes, end-organ damage, sitting diastolic and systolic blood pressures, pulse, hematocrit, smoking status, and relative weight (percent of ideal weight)--in assessing group differences in mortality rates, a multiple logistic model was used. Relative weight proved to be a confounding factor for the association of drop in postural systolic blood pressure with mortality. However, there is an interaction between history of diabetes and postural change in systolic blood pressure. Thus, postural hypotension may indicate a poor prognosis in diabetic hypertensive patients.

Entities:  

Mesh:

Year:  1987        PMID: 3802437     DOI: 10.1161/01.cir.75.2.340

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Postural hypotension and falls.

Authors:  T Kwok; J Liddle; I R Hastie
Journal:  Postgrad Med J       Date:  1995-05       Impact factor: 2.401

2.  Influence of age on the immediate cardiovascular response to orthostatic manoeuvre.

Authors:  G Cybulski
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

3.  Racial and ethnic differences in longitudinal blood pressure control in veterans with type 2 diabetes mellitus.

Authors:  R Neal Axon; Mulugeta Gebregziabher; Carrae Echols; Gregory Gilbert Msph; Leonard E Egede
Journal:  J Gen Intern Med       Date:  2011-06-14       Impact factor: 5.128

4.  Influence of orthostatic hypotension on mortality among patients discharged from an acute geriatric ward.

Authors:  Avraham Weiss; Yichayaou Beloosesky; Ran Kornowski; Alexandra Yalov; Joseph Grinblat; Ehud Grossman
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

Review 5.  Preventing and treating orthostatic hypotension: As easy as A, B, C.

Authors:  Juan J Figueroa; Jeffrey R Basford; Phillip A Low
Journal:  Cleve Clin J Med       Date:  2010-05       Impact factor: 2.321

6.  Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study.

Authors:  Christine D Jones; Laura Loehr; Nora Franceschini; Wayne D Rosamond; Patricia P Chang; Eyal Shahar; David J Couper; Kathryn M Rose
Journal:  Hypertension       Date:  2012-03-19       Impact factor: 10.190

Review 7.  Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications.

Authors:  Ihab Hajjar
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Orthostatic hypotension and anti-hypertensive therapy in the elderly.

Authors:  M D Fotherby; J F Potter
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

9.  Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.

Authors:  Raymond R Townsend; Tara I Chang; Debbie L Cohen; William C Cushman; Gregory W Evans; Stephen P Glasser; William E Haley; Christine Olney; Suzanne Oparil; Rita Del Pinto; Roberto Pisoni; Addison A Taylor; Kausik Umanath; Jackson T Wright; Joseph Yeboah
Journal:  J Am Soc Hypertens       Date:  2016-08-26

10.  Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.

Authors:  Jerome L Fleg; Gregory W Evans; Karen L Margolis; Joshua Barzilay; Jan N Basile; J Thomas Bigger; Jeffrey A Cutler; Richard Grimm; Carolyn Pedley; Kevin Peterson; Rodica Pop-Busui; JoAnn Sperl-Hillen; William C Cushman
Journal:  Hypertension       Date:  2016-08-08       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.